| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/08/2023 | CalciMedica, Inc. | GRAY | Grant | Director Stock Option (Right to Buy) | 20k | $3.25 | $65k | | 05/08/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Common Stock | 181.7k | $0.00 | $0 | | 03/20/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Director Stock Option (right to buy) | 23.6k | $6.60 | $155.5k | | 03/20/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Director Stock Option (right to buy) | 5.8k | $7.99 | $46k | | 03/20/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Director Stock Option (right to buy) | 7.6k | $17.34 | $131.4k | | 03/20/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Director Stock Option (right to buy) | 1.5k | $17.34 | $25.8k | | 03/20/2023 |
| 03/20/2023 | CalciMedica, Inc. | GRAY | Grant | Warrant | 8.6k | $27.94 | $240.1k | | 03/20/2023 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 4.8k | $41.75 | $199.8k | | 12/13/2018 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 5k | $41.75 | $208.7k | | 12/13/2018 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 6.6k | $41.75 | $275.5k | | 12/13/2018 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 11.3k | $17.62 | $199.9k | | 12/13/2018 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 14.3k | $19.21 | $275.6k | | 12/13/2018 |
| 12/13/2018 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 16.5k | $12.66 | $208.8k | | 12/13/2018 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 3.5k | $43.50 | $150.4k | | 10/18/2017 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 4.4k | $43.50 | $192.6k | | 10/18/2017 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 11.1k | $17.38 | $192.6k | | 10/18/2017 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 8.4k | $18.00 | $150.4k | | 10/18/2017 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Exercise | Nonqualified Stock Option (right to buy) | 7.5k | $22.39 | $167.6k | | 10/18/2017 |
| 10/18/2017 | SCHWAB CHARLES CORP | SCHW | Payment of Exercise | Common Stock | 3.9k | $43.50 | $167.6k | | 10/18/2017 |
| 05/18/2017 | SCHWAB CHARLES CORP | SCHW | Grant | Common Stock | 1.8k | $0.00 | $0 | | 05/18/2017 |
| 05/18/2017 | SCHWAB CHARLES CORP | SCHW | Grant | Nonqualified Stock Option (right to buy) | 7.2k | $38.33 | $274.6k | | 05/18/2017 |
| 06/04/2013 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock | 10k | $5.00 | $50k | | 06/04/2013 |
| 01/02/2013 | SCHWAB CHARLES CORP | SCHW | Grant | Restricted Stock Units | 954 | $0.00 | $0 | | 01/02/2013 |
| 11/13/2012 | HESS CORP | HES | Purchase | Common Stock, $1.00 par value | 5k | $50.16 | $250.8k | | 11/13/2012 |
| 02/02/2011 | HESS CORP | HES | Grant | Common Stock, $1.00 par value | 1.8k | $0.00 | $0 | | 02/02/2011 |
| 07/01/2010 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Common Stock | 7.7k | $0.00 | $0 | | 07/01/2010 |
| 07/01/2010 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Director Stock Option (Right to Buy) | 5.5k | $2.59 | $14.2k | | 07/01/2010 |
| 02/03/2010 | HESS CORP | HES | Grant | Common Stock, $1.00 par value | 2.5k | $0.00 | $0 | | 02/03/2010 |